Evidence map›Paper›PMID 41994012›Full record

ArticleESMO gastrointestinal oncology2026

Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].

A Gandini, V Martelli, L Belgioia, S Puglisi, M Cremante, V Murianni, A Damassi, C Pirrone, F Catalano, M Grassi and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

A GandiniDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
V MartelliDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
L BelgioiaHealth Science Department (DISSAL), University of Genoa, Genoa, Italy.
S PuglisiDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
M CremanteDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
V MurianniDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
A DamassiDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
C PirroneDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
F CatalanoDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
M GrassiDepartment of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
L TrevisanUnit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
S VaggeRadiotherapy Department, E.O. Ospedali Galliera, Genoa, Italy.
V AndrettaMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
S MammolitiMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
D ComandiniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
G FornariniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
A PessinoMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
A PastorinoMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
S ScialleroMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
A PucciniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
A F SobreroMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.esmogo.2024.100069.].

Identifiers

PMID41994012
PMCPMC13080798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.